The PEGS Boston Summit brings together leading experts at the forefront of biologics innovation, providing insights into the latest technologies, research, and advancements in drug development, protein and antibody engineering, immunotherapy, immunogenicity, expression platforms, multispecific antibodies, machine learning and AI in biologics, and more.

The Biochemical and Molecular Engineering conference series brings together researchers from across engineering disciplines and the natural sciences to discuss recent progress in this broad field, network with experts across a wide range of specialties, and brainstorm new approaches to address global challenges facing biotechnology and society at large. This will be the twenty third edition of a conference series dating back to the dawn of the recombinant DNA era. This year the steering committee is thrilled to hold the meeting in Ireland – an emerging hub for biotechnology and biopharma, where we aim to expand our network and form a bridge between North American and European biotech. We hope you will consider joining us for a week of fun, vigorous scientific discourse in the friendly atmosphere of Dublin, Ireland. Please spread the word to your colleagues, particularly your younger colleagues, so the 2024 meeting can add to the long list of successful meetings in this series.

This year’s conference is a “must attend” to discover fresh solutions for energy, food, and environmental sustainability provided by industrial biotech. As always, the conference provides a great opportunity to meet new colleagues as well as to catch up with old friends.

Each year, more than 3000+ bioprocessing professionals representing 40+ countries attend BioProcess International in Boston to learn about today's innovative science across the entire spectrum of biopharmaceutical development and production.

The Annual Product Show is the premier one-day biopharmaceutical show in the Northeast and the flagship event of the ISPE Boston Area Chapter. Recognized as one of the leading ISPE chapters in the world, the success of the Boston Area Chapter, the Product Show, and the local industry as a whole is in large part due to the collaboration, knowledge sharing and best practices of our members and volunteers.

DCVMN is a voluntary public health driven alliance of vaccine manufacturers from developing countries that aims to make a consistent supply of high quality vaccines that are accessible to protect people against known and emerging infectious diseases globally.

ICB VI will bring together leading scientists and engineers from academia, industry and regulatory who are actively engaged in creating and enabling integrated continuous biomanufacturing. We look forward to welcoming invitees to Leesburg, Virginia, USA to reflect on the field’s progress and to harness our collective capabilities to drive towards a more efficient and sustainable future.